Skip to content

    PALVELLA THERAPEUTICS (PVLA) stock price & financials

    View PVLA earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+165.7% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $0
    Operating Profit
    -$5.06M
    -$4.37M
    -$7.87M
    -$9.25M
    -$10.18M
    -101.0%
    -$11.30M
    -158.9%
    -$14.86M
    -88.7%
    -$21.41M
    -131.4%
    Weakening
    Net Profit
    -$6.78M
    -$3.95M
    -$8.19M
    -$9.47M
    -$11.35M
    -67.5%
    -$12.71M
    -221.8%
    -$15.77M
    -92.6%
    -$21.87M
    -130.9%
    Weakening
    EPS
    $-3.94
    $-0.74
    $-0.86
    $-1.03
    +73.9%
    $-1.20
    -62.2%
    $-1.52
    -76.7%
    Weakening
    Other Income
    Interest
    Depreciation
    Profit before Tax
    -$6.78M
    -$3.95M
    -$8.19M
    -$9.47M
    -$11.35M
    -67.5%
    -$12.71M
    -221.8%
    -$15.77M
    -92.6%
    -$21.87M
    -130.9%
    Weakening
    MarginsOPM
    Tax
    0.0%
    0.0%
    0.0%
    0.0%
    0.0%
    0.0%
    0.0%
    0.0%
    ReturnsROIC
    3.9%
    2.3%
    4.7%
    5.5%
    6.6%
    +67.5%
    7.3%
    +221.8%
    9.1%
    +92.6%
    12.6%
    +130.9%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$74.87M$62.26M$70.44M$117.76M$38.63M$7.35M$83.60M$57.98M$187.80M
    Short-Term Investments
    Total Current Assets$135.38M$115.01M$75.72M$127.63M$73.42M$7.55M$88.23M$58.99M$253.03M
    Net PP&E$5.05M$22.94M$25.98M$23.03M$20.70M$0$0$572.0K$482.0K
    Goodwill
    Intangibles
    Total Assets$141.34M$141.10M$105.01M$153.56M$95.49M$7.55M$88.23M$59.56M$253.51M
    LiabilitiesTotal Current Liabilities$48.08M$27.00M$22.14M$50.56M$36.58M$2.36M$12.04M$11.34M$11.95M
    Short-Term Debt
    Long-Term Debt
    Long-Term Leases$0$15.48M$15.93M$13.84M$12.24M$0$0$431.0K$318.0K
    Total Liabilities$101.41M$89.75M$73.98M$102.81M$67.56M$11.43M$25.63M$31.58M$36.64M
    EquityCommon Stock & APIC$54.0K$55.0K$56.0K$72.0K$74.0K$0$11.0K$12.0K$14.0K
    Retained Earnings-$147.07M-$174.18M-$211.41M-$257.14M-$290.42M-$76.30M-$93.73M-$135.45M-$173.09M
    Total Equity$39.94M$51.35M$31.03M$50.76M-$93.78M-$74.48M$62.61M$27.98M$216.87M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$1.07M-$52.47M-$45.90M-$7.66M-$59.93M-$13.70M-$10.84M-$25.01M-$36.51M
    Cash from Investing-$8.88M$9.84M$39.21M-$949.0K-$21.24M$12.00M
    Cash from Financing$48.51M$32.17M$10.12M$59.13M$7.21M$5.00M$87.09M-$660.0K$216.20M
    SummaryCapital Expenditure-$1.70M-$2.46M-$2.73M-$949.0K-$1.04M-$171.0K
    Free Cash Flow-$2.76M-$54.93M-$48.62M-$8.61M-$60.97M-$13.87M
    FCF Margin-9.5%-118.7%-165.8%-27.4%-235.4%-32.4%

    Ratios